XL184 80mg (Cometriq 80 mg)
Generic Name: cabozantinib
Pill imprint XL184 80mg has been identified as Cometriq 80 mg.
Cometriq is used in the treatment of thyroid cancer and belongs to the drug classes multikinase inhibitors, VEGF/VEGFR inhibitors. There is positive evidence of human fetal risk during pregnancy. Cometriq 80 mg is not a controlled substance under the Controlled Substance Act (CSA).
More about Cometriq (cabozantinib)
- Other brands: Cabometyx
Related treatment guides
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2017 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.